ZA200710715B - Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds - Google Patents

Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds

Info

Publication number: ZA200710715B
Authority: ZA; South Africa
Prior art keywords: nanoparticulate; aryl; controlled release; heterocyclic compounds; release compositions
Prior art date: 2005-06-20

Application number

ZA200710715A

Inventor

Devane John

Stark Paul

Fanning Niall

Rekhi Gurvinder Singh

Jenkins Scott

Liversidge Gary

Original Assignee

Elan Pharma Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-20

Filing date

2007-12-10

Publication date

2009-03-25

2007-12-10 Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd

2009-03-25 Publication of ZA200710715B publication Critical patent/ZA200710715B/en

Links

ZA200710715A 2005-06-20 2007-12-10 Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds ZA200710715B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US69209605P	2005-06-20	2005-06-20

Publications (1)

Publication Number	Publication Date
ZA200710715B true ZA200710715B (en)	2009-03-25

Family

ID=39933852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200710715A ZA200710715B (en)	2005-06-20	2007-12-10	Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds

Country Status (4)

Country	Link
JP (1)	JP2008546781A (en)
CN (1)	CN101242813A (en)
MX (1)	MX2007016151A (en)
ZA (1)	ZA200710715B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8951996B2 (en) *	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
US9956194B2 (en) *	2014-12-03	2018-05-01	Velicept Therapeutics, Inc.	Compositions and methods of using modified release solabegron for lower urinary tract symptoms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150366A (en) *	1998-06-15	2000-11-21	Pfizer Inc.	Ziprasidone formulations
AR046811A1 (en) *	2003-09-02	2005-12-28	Imran Ahmed	ORAL DOSAGE FORMS OF ZIPRASIDONE OF SUSTAINED LIBERATION
WO2006109183A1 (en) *	2005-04-13	2006-10-19	Pfizer Products Inc.	Injectable depot formulations and methods for providing sustained release of nanoparticle compositions

2006
- 2006-06-19 CN CNA2006800302325A patent/CN101242813A/en active Pending
- 2006-06-19 MX MX2007016151A patent/MX2007016151A/en not_active Application Discontinuation
- 2006-06-19 JP JP2008518266A patent/JP2008546781A/en active Pending
2007
- 2007-12-10 ZA ZA200710715A patent/ZA200710715B/en unknown

Also Published As

Publication number	Publication date
MX2007016151A (en)	2008-03-06
JP2008546781A (en)	2008-12-25
CN101242813A (en)	2008-08-13

Similar Documents

Publication	Publication Date	Title
ZA200708260B (en)	2010-05-26	Nanoparticulate and controlled release compositions comprising cyclosporine
ZA200802602B (en)	2009-10-28	Controlled release formulation
IL184174A0 (en)	2008-01-20	Nanoparticulate and controlled release compositions comprising cephalosporin
IL244442B (en)	2018-05-31	Substituted acylanilide compounds and uses thereof
GB0406819D0 (en)	2004-04-28	Controlled release compositions
ZA200705384B (en)	2008-09-25	Nanoparticulate candesartan formulations
IL199006A0 (en)	2010-02-17	Nanoparticulate formulations and methods for the making and use thereof
ZA200708702B (en)	2008-11-26	Nanoparticulate quinazoline derivative formulations
ZA200805646B (en)	2009-12-30	Controlled release solid preparation
PL1959925T3 (en)	2017-05-31	Controlled release microparticles
IL186778A0 (en)	2008-02-09	Stabilized composition
ZA200805706B (en)	2010-02-24	Controlled release solid preparation
GB0621160D0 (en)	2006-12-06	Compounds and uses thereof
GB0615213D0 (en)	2006-09-06	Fungicidal compounds and compositions
IL187431A0 (en)	2011-08-01	Nanoparticulate and controlled release compositions comprising a cephalosporin
HK1117060A1 (en)	2009-01-09	Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds
IL185223A0 (en)	2008-06-05	Compounds and uses thereof
EP2124908A4 (en)	2011-04-27	Compounds and uses thereof
EP2098544A4 (en)	2013-10-16	Polymerizable compounds and polymerizable compositions
EP1849481A4 (en)	2012-11-28	Composition for external use
GB0720887D0 (en)	2007-12-05	Nanoparticulate and controlled release compositions comprising prostaglandin derivatives
IL202496A0 (en)	2010-06-30	Compounds and uses thereof 849
EP2120563A4 (en)	2011-04-27	Compounds and uses thereof
EP1954253A4 (en)	2011-07-27	Nanoparticulate and controlled release compositions comprising cefditoren
EP2099459A4 (en)	2011-04-27	Compounds and uses thereof